Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Gene-environment interactions in case-control studies with silent disease.

Lobach I, Sampson J, Lobach S, Zhang L.

Genet Epidemiol. 2018 Jun 13. doi: 10.1002/gepi.22135. [Epub ahead of print]

PMID:
29896809
2.

Michelson mode selector for spectral range stabilization in a self-sweeping fiber laser.

Tkachenko AY, Vladimirskaya AD, Lobach IA, Kablukov SI.

Opt Lett. 2018 Apr 1;43(7):1558-1561. doi: 10.1364/OL.43.001558.

PMID:
29601029
3.

Raman fiber laser with random distributed feedback based on a twin-core fiber.

Budarnykh AE, Lobach IA, Zlobina EA, Velmiskin VV, Kablukov SI, Semjonov SL, Babin SA.

Opt Lett. 2018 Feb 1;43(3):567-570. doi: 10.1364/OL.43.000567.

PMID:
29400842
4.

Synovial Fluid Profile at the Time of Anterior Cruciate Ligament Reconstruction and Its Association With Cartilage Matrix Composition 3 Years After Surgery.

Amano K, Huebner JL, Stabler TV, Tanaka M, McCulloch CE, Lobach I, Lane NE, Kraus VB, Ma CB, Li X.

Am J Sports Med. 2018 Mar;46(4):890-899. doi: 10.1177/0363546517749834. Epub 2018 Jan 24.

PMID:
29364702
5.

Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.

Santos-Santos MA, Rabinovici GD, Iaccarino L, Ayakta N, Tammewar G, Lobach I, Henry ML, Hubbard I, Mandelli ML, Spinelli E, Miller ZA, Pressman PS, O'Neil JP, Ghosh P, Lazaris A, Meyer M, Watson C, Yoon SJ, Rosen HJ, Grinberg L, Seeley WW, Miller BL, Jagust WJ, Gorno-Tempini ML.

JAMA Neurol. 2018 Mar 1;75(3):342-352. doi: 10.1001/jamaneurol.2017.4309.

6.

CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.

Rojas JC, Bang J, Lobach IV, Tsai RM, Rabinovici GD, Miller BL, Boxer AL; AL-108-231 Investigators.

Neurology. 2018 Jan 23;90(4):e273-e281. doi: 10.1212/WNL.0000000000004859. Epub 2017 Dec 27.

PMID:
29282336
7.

Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.

Ray KM, Kerlikowske K, Lobach IV, Hofmann MB, Greenwood HI, Arasu VA, Hylton NM, Joe BN.

Radiology. 2018 Mar;286(3):822-829. doi: 10.1148/radiol.2017170811. Epub 2017 Oct 25.

PMID:
29072981
8.

Open-cavity fiber laser with distributed feedback based on externally or self-induced dynamic gratings.

Lobach IA, Drobyshev RV, Fotiadi AA, Podivilov EV, Kablukov SI, Babin SA.

Opt Lett. 2017 Oct 15;42(20):4207-4210. doi: 10.1364/OL.42.004207.

PMID:
29028049
9.

Clustered Microcysts on Breast Ultrasound: What Is an Appropriate Management Recommendation?

Greenwood HI, Lee AY, Lobach IV, Carpentier BM, Freimanis RI, Strachowski LM.

AJR Am J Roentgenol. 2017 Dec;209(6):W395-W399. doi: 10.2214/AJR.17.17813. Epub 2017 Sep 20.

PMID:
28929806
10.

Linearly polarized cascaded Raman fiber laser with random distributed feedback operating beyond 1.5  μm.

Lobach IA, Kablukov SI, Babin SA.

Opt Lett. 2017 Sep 15;42(18):3526-3529. doi: 10.1364/OL.42.003526.

PMID:
28914892
11.

All-fiber Brillouin optical spectrum analyzer based on self-sweeping fiber laser.

Tkachenko AY, Lobach IA, Kablukov SI.

Opt Express. 2017 Jul 24;25(15):17600-17605. doi: 10.1364/OE.25.017600.

PMID:
28789252
12.

Incorporation of interfacial roughness into recursion matrix formalism of dynamical X-ray diffraction in multilayers and superlattices.

Lobach I, Benediktovitch A, Ulyanenkov A.

J Appl Crystallogr. 2017 Apr 13;50(Pt 3):681-688. doi: 10.1107/S1600576717004137. eCollection 2017 Jun 1.

13.

Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease.

Goetzl EJ, Schwartz JB, Mustapic M, Lobach IV, Daneman R, Abner EL, Jicha GA.

FASEB J. 2017 Aug;31(8):3689-3694. doi: 10.1096/fj.201700149. Epub 2017 May 5.

14.

A multicenter study to define sarcopenia in patients with end-stage liver disease.

Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano-Loza AJ, Dunn MA; Fitness, Life Enhancement, and Exercise in Liver Transplantation Consortium.

Liver Transpl. 2017 May;23(5):625-633. doi: 10.1002/lt.24750.

15.

Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.

Woerman AL, Aoyagi A, Patel S, Kazmi SA, Lobach I, Grinberg LT, McKee AC, Seeley WW, Olson SH, Prusiner SB.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8187-E8196. Epub 2016 Nov 28.

16.

Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease.

Goetzl EJ, Mustapic M, Kapogiannis D, Eitan E, Lobach IV, Goetzl L, Schwartz JB, Miller BL.

FASEB J. 2016 Nov;30(11):3853-3859. Epub 2016 Aug 10.

17.

Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage.

Bertoux M, Sarazin M, Pasquier F, Bottlaender M, de Souza LC, Mioshi E, Hornberger M, Ranasinghe KG, Rankin KP, Lobach IV, Kramer JH, Sturm VE, Bettcher BM, Possin K, You SC, Lamarre AK, Shany-Ur T, Stephens ML, Perry DC, Lee SE, Miller ZA, Gorno-Tempini ML, Rosen HJ, Boxer A, Seeley WW, Rabinovici GD, Vossel KA, Miller BL.

Neurology. 2016 Oct 4;87(14):1523. No abstract available.

18.

Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease.

Goetzl EJ, Kapogiannis D, Schwartz JB, Lobach IV, Goetzl L, Abner EL, Jicha GA, Karydas AM, Boxer A, Miller BL.

FASEB J. 2016 Dec;30(12):4141-4148. Epub 2016 Sep 6.

19.

Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma.

Daud AI, Loo K, Pauli ML, Sanchez-Rodriguez R, Sandoval PM, Taravati K, Tsai K, Nosrati A, Nardo L, Alvarado MD, Algazi AP, Pampaloni MH, Lobach IV, Hwang J, Pierce RH, Gratz IK, Krummel MF, Rosenblum MD.

J Clin Invest. 2016 Sep 1;126(9):3447-52. doi: 10.1172/JCI87324. Epub 2016 Aug 15.

20.

Narrowband random lasing in a Bismuth-doped active fiber.

Lobach IA, Kablukov SI, Skvortsov MI, Podivilov EV, Melkumov MA, Babin SA, Dianov EM.

Sci Rep. 2016 Jul 20;6:30083. doi: 10.1038/srep30083.

21.

Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network Degeneration.

Ranasinghe KG, Rankin KP, Pressman PS, Perry DC, Lobach IV, Seeley WW, Coppola G, Karydas AM, Grinberg LT, Shany-Ur T, Lee SE, Rabinovici GD, Rosen HJ, Gorno-Tempini ML, Boxer AL, Miller ZA, Chiong W, DeMay M, Kramer JH, Possin KL, Sturm VE, Bettcher BM, Neylan M, Zackey DD, Nguyen LA, Ketelle R, Block N, Wu TQ, Dallich A, Russek N, Caplan A, Geschwind DH, Vossel KA, Miller BL.

JAMA Neurol. 2016 Sep 1;73(9):1078-88. doi: 10.1001/jamaneurol.2016.2016.

22.

Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells In Vitro.

Heilmeier U, Hackl M, Skalicky S, Weilner S, Schroeder F, Vierlinger K, Patsch JM, Baum T, Oberbauer E, Lobach I, Burghardt AJ, Schwartz AV, Grillari J, Link TM.

J Bone Miner Res. 2016 Dec;31(12):2173-2192. doi: 10.1002/jbmr.2897. Epub 2016 Sep 26.

23.

Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.

Bang J, Lobach IV, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Gold M, Morimoto BH, Boxer AL; AL-108-231 Investigators.

Parkinsonism Relat Disord. 2016 Jul;28:41-48. doi: 10.1016/j.parkreldis.2016.04.014. Epub 2016 Apr 18.

24.

Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.

Tsai RM, Lobach I, Bang J, Whitwell JL, Senjem ML, Jack CR Jr, Rosen H, Miller B, Boxer AL; AL-108-231 Investigators.

Parkinsonism Relat Disord. 2016 Jul;28:29-35. doi: 10.1016/j.parkreldis.2016.04.006. Epub 2016 Apr 24.

25.

Real-time high-resolution heterodyne-based measurements of spectral dynamics in fibre lasers.

Sugavanam S, Fabbri S, Le ST, Lobach I, Kablukov S, Khorev S, Churkin D.

Sci Rep. 2016 Mar 17;6:23152. doi: 10.1038/srep23152.

26.

Intravenous heparin dosing strategy in hospitalized patients with atrial dysrhythmias.

Roswell RO, Greet B, Shah S, Bernard S, Milin A, Lobach I, Guo Y, Radford MJ, Berger JS.

J Thromb Thrombolysis. 2016 Aug;42(2):179-85. doi: 10.1007/s11239-016-1347-2.

PMID:
26951166
27.

Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy.

Stamelou M, Schöpe J, Wagenpfeil S, Del Ser T, Bang J, Lobach IY, Luong P, Respondek G, Oertel WH, Boxer A, Höglinger GU; AL-108-231 Investigators, Tauros Investigators, and MDS-Endorsed PSP Study Group.

Mov Disord. 2016 May;31(5):742-7. doi: 10.1002/mds.26580. Epub 2016 Mar 7. Review.

28.

Adverse Trends in Ischemic Heart Disease Mortality among Young New Yorkers, Particularly Young Black Women.

Smilowitz NR, Maduro GA Jr, Lobach IV, Chen Y, Reynolds HR.

PLoS One. 2016 Feb 16;11(2):e0149015. doi: 10.1371/journal.pone.0149015. eCollection 2016.

29.

Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage.

Ranasinghe KG, Rankin KP, Lobach IV, Kramer JH, Sturm VE, Bettcher BM, Possin K, Christine You S, Lamarre AK, Shany-Ur T, Stephens ML, Perry DC, Lee SE, Miller ZA, Gorno-Tempini ML, Rosen HJ, Boxer A, Seeley WW, Rabinovici GD, Vossel KA, Miller BL.

Neurology. 2016 Feb 16;86(7):600-10. doi: 10.1212/WNL.0000000000002373. Epub 2016 Jan 22.

30.

Identifying preoperative language tracts and predicting postoperative functional recovery using HARDI q-ball fiber tractography in patients with gliomas.

Caverzasi E, Hervey-Jumper SL, Jordan KM, Lobach IV, Li J, Panara V, Racine CA, Sankaranarayanan V, Amirbekian B, Papinutto N, Berger MS, Henry RG.

J Neurosurg. 2016 Jul;125(1):33-45. doi: 10.3171/2015.6.JNS142203. Epub 2015 Dec 11.

PMID:
26654181
31.

Single-frequency Bismuth-doped fiber laser with quasi-continuous self-sweeping.

Lobach IA, Kablukov SI, Melkumov MA, Khopin VF, Babin SA, Dianov EM.

Opt Express. 2015 Sep 21;23(19):24833-42. doi: 10.1364/OE.23.024833.

PMID:
26406683
32.

Fourier synthesis with single-mode pulses from a multimode laser.

Lobach IA, Kablukov SI, Podivilov EV, Fotiadi AA, Babin SA.

Opt Lett. 2015 Aug 1;40(15):3671-4. doi: 10.1364/OL.40.003671.

PMID:
26258385
33.

Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease.

Forner SA, Takada LT, Bettcher BM, Lobach IV, Tartaglia MC, Torres-Chae C, Haman A, Thai J, Vitali P, Neuhaus J, Bostrom A, Miller BL, Rosen HJ, Geschwind MD.

Neurol Clin Pract. 2015 Apr;5(2):116-125.

34.

Gene Level Meta-Analysis of Quantitative Traits by Functional Linear Models.

Fan R, Wang Y, Boehnke M, Chen W, Li Y, Ren H, Lobach I, Xiong M.

Genetics. 2015 Aug;200(4):1089-104. doi: 10.1534/genetics.115.178343. Epub 2015 Jun 9.

35.

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.

Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA, Hauser SL, Henry RG.

JAMA Neurol. 2015 Aug;72(8):897-904. doi: 10.1001/jamaneurol.2015.0993.

36.

Diabetes and ischemic heart disease death in people age 25-54: a multiple-cause-of-death analysis based on over 400 000 deaths from 1990 to 2008 in New York City.

Quinones A, Lobach I, Maduro GA Jr, Smilowitz NR, Reynolds HR.

Clin Cardiol. 2015 Feb;38(2):114-20. doi: 10.1002/clc.22367.

37.

White matter involvement in sporadic Creutzfeldt-Jakob disease.

Caverzasi E, Mandelli ML, DeArmond SJ, Hess CP, Vitali P, Papinutto N, Oehler A, Miller BL, Lobach IV, Bastianello S, Geschwind MD, Henry RG.

Brain. 2014 Dec;137(Pt 12):3339-54. doi: 10.1093/brain/awu298. Epub 2014 Nov 2.

38.

A risk score for prediction of hyperglycemia at coronary angiography.

Shah B, Burdowski J, Lobach I, Gianos E, Sedlis SP.

JACC Cardiovasc Interv. 2014 Oct;7(10):1199-201. doi: 10.1016/j.jcin.2014.06.009. Epub 2014 Sep 17. No abstract available.

39.

Generalized functional linear models for gene-based case-control association studies.

Fan R, Wang Y, Mills JL, Carter TC, Lobach I, Wilson AF, Bailey-Wilson JE, Weeks DE, Xiong M.

Genet Epidemiol. 2014 Nov;38(7):622-637. doi: 10.1002/gepi.21840. Epub 2014 Sep 9.

40.

Interleukin-6, age, and corpus callosum integrity.

Bettcher BM, Watson CL, Walsh CM, Lobach IV, Neuhaus J, Miller JW, Green R, Patel N, Dutt S, Busovaca E, Rosen HJ, Yaffe K, Miller BL, Kramer JH.

PLoS One. 2014 Sep 4;9(9):e106521. doi: 10.1371/journal.pone.0106521. eCollection 2014.

41.

Spinal cord gray matter atrophy correlates with multiple sclerosis disability.

Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, Cree BA, Hauser SL, Henry RG.

Ann Neurol. 2014 Oct;76(4):568-80. doi: 10.1002/ana.24241. Epub 2014 Aug 21.

42.

Frontal white matter tracts sustaining speech production in primary progressive aphasia.

Mandelli ML, Caverzasi E, Binney RJ, Henry ML, Lobach I, Block N, Amirbekian B, Dronkers N, Miller BL, Henry RG, Gorno-Tempini ML.

J Neurosci. 2014 Jul 16;34(29):9754-67. doi: 10.1523/JNEUROSCI.3464-13.2014.

43.

Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.

Wagshal D, Sankaranarayanan S, Guss V, Hall T, Berisha F, Lobach I, Karydas A, Voltarelli L, Scherling C, Heuer H, Tartaglia MC, Miller Z, Coppola G, Ahlijanian M, Soares H, Kramer JH, Rabinovici GD, Rosen HJ, Miller BL, Meredith J, Boxer AL.

J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):244-50. doi: 10.1136/jnnp-2014-308004. Epub 2014 Jun 4.

44.

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.

Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, Roberson ED, Höglinger GU, Koestler M, Jack CR Jr, Van Deerlin V, Randolph C, Lobach IV, Heuer HW, Gozes I, Parker L, Whitaker S, Hirman J, Stewart AJ, Gold M, Morimoto BH; AL-108-231 Investigators.

Lancet Neurol. 2014 Jul;13(7):676-85. doi: 10.1016/S1474-4422(14)70088-2. Epub 2014 May 27.

45.

From door-to-balloon time to contact-to-device time: predictors of achieving target times in patients with ST-elevation myocardial infarction.

Roswell RO, Greet B, Parikh P, Mignatti A, Freese J, Lobach I, Guo Y, Keller N, Radford M, Bangalore S.

Clin Cardiol. 2014 Jul;37(7):389-94. doi: 10.1002/clc.22278. Epub 2014 Apr 3.

46.

Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention.

Shah B, Berger JS, Amoroso NS, Mai X, Lorin JD, Danoff A, Schwartzbard AZ, Lobach I, Guo Y, Feit F, Slater J, Attubato MJ, Sedlis SP.

Am J Cardiol. 2014 May 1;113(9):1474-80. doi: 10.1016/j.amjcard.2014.01.428. Epub 2014 Feb 12.

47.

Application of quantitative DTI metrics in sporadic CJD.

Caverzasi E, Henry RG, Vitali P, Lobach IV, Kornak J, Bastianello S, Dearmond SJ, Miller BL, Rosen HJ, Mandelli ML, Geschwind MD.

Neuroimage Clin. 2014 Jan 31;4:426-35. doi: 10.1016/j.nicl.2014.01.011. eCollection 2014.

48.
49.

Handedness and language learning disability differentially distribute in progressive aphasia variants.

Miller ZA, Mandelli ML, Rankin KP, Henry ML, Babiak MC, Frazier DT, Lobach IV, Bettcher BM, Wu TQ, Rabinovici GD, Graff-Radford NR, Miller BL, Gorno-Tempini ML.

Brain. 2013 Nov;136(Pt 11):3461-73. doi: 10.1093/brain/awt242. Epub 2013 Sep 20.

50.

Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories.

Berger JS, Hochman J, Lobach I, Adelman MA, Riles TS, Rockman CB.

J Vasc Surg. 2013 Sep;58(3):673-81.e1. doi: 10.1016/j.jvs.2013.01.053. Epub 2013 May 2.

Supplemental Content

Loading ...
Support Center